Ensysce Biosciences Inc. Revenue 2020–2025
Ensysce Biosciences Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ensysce Biosciences Inc. revenue for the quarter ending March 31, 2026 was 960999, a 27.18% decrease year-over-year.
- Ensysce Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 4.1 M, a 4.52% decrease year-over-year.
- Ensysce Biosciences Inc. annual revenue for 2025 was 5.1 M, a 2.75% decrease from 2024.
- Ensysce Biosciences Inc. annual revenue for 2024 was 5.2 M, a 133.58% increase from 2023.
- Ensysce Biosciences Inc. annual revenue for 2023 was 2.2 M, a 11.61% decrease from 2022.
- Ensysce Biosciences Inc. annual revenue for 2022 was 2.5 M.
Ensysce Biosciences Inc. (ENSC) — Frequently Asked Questions
Ensysce Biosciences Inc. (ENSC) is a publicly traded US company. It has a market capitalization of $649,573.784. In fiscal 2025 it reported revenue of $5M. Explore ENSC's stock price, financial statements, earnings history, margins and key ratios below.
What is Ensysce Biosciences Inc.'s market cap?
Ensysce Biosciences Inc. (ENSC) has a market capitalization of $649,573.784.
What is the ENSC stock price?
ENSC trades at $0.25.
How much revenue does Ensysce Biosciences Inc. make?
Ensysce Biosciences Inc. reported revenue of $5M in fiscal 2025.